Pharma-Bio Serv, Inc. (PBSV)
0.4161
-0.05
(-10.15%)
USD |
OTCM |
Oct 07, 16:00
Pharma-Bio Serv Enterprise Value : 0.9517M for Oct. 7, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 07, 2026 | 0.9517M |
| October 06, 2026 | 2.028M |
| October 05, 2026 | 2.028M |
| October 02, 2026 | 2.874M |
| October 01, 2026 | 1.729M |
| September 30, 2026 | 1.729M |
| September 29, 2026 | 1.729M |
| September 28, 2026 | -0.5616M |
| September 25, 2026 | 1.500M |
| September 24, 2026 | 1.500M |
| September 23, 2026 | 1.500M |
| September 22, 2026 | 1.500M |
| September 21, 2026 | 2.184M |
| September 18, 2026 | 2.046M |
| September 17, 2026 | 2.046M |
| September 16, 2026 | 0.5835M |
| September 15, 2026 | 1.729M |
| September 14, 2026 | 3.790M |
| September 11, 2026 | 3.790M |
| September 10, 2026 | 3.790M |
| September 09, 2026 | 3.790M |
| September 08, 2026 | 3.790M |
| September 04, 2026 | 3.790M |
| September 03, 2026 | 2.216M |
| September 02, 2026 | 3.787M |
| Date | Value |
|---|---|
| September 01, 2026 | 1.112M |
| August 31, 2026 | 3.790M |
| August 28, 2026 | 3.790M |
| August 27, 2026 | 3.790M |
| August 26, 2026 | 3.790M |
| August 25, 2026 | 3.790M |
| August 24, 2026 | 3.790M |
| August 21, 2026 | 3.790M |
| August 20, 2026 | 3.790M |
| August 19, 2026 | 1.099M |
| August 18, 2026 | 3.787M |
| August 17, 2026 | 3.787M |
| August 14, 2026 | 3.787M |
| August 13, 2026 | 3.787M |
| August 12, 2026 | 3.787M |
| August 11, 2026 | 3.787M |
| August 10, 2026 | 1.103M |
| August 07, 2026 | 4.706M |
| August 06, 2026 | 4.706M |
| August 05, 2026 | 4.706M |
| August 04, 2026 | 1.099M |
| August 03, 2026 | 1.099M |
| July 31, 2026 | 1.099M |
| July 30, 2026 | 1.204M |
| July 29, 2026 | 1.204M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Cryoport, Inc. | 760.35M |
| ICON plc | 15.26B |
| IQVIA Holdings, Inc. | 56.78B |
| Eurofins Scientific SE | -- |
| Proteome Sciences Plc | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.0142M |
| Revenue (Quarterly) | 2.336M |
| Total Expenses (Quarterly) | 2.350M |
| EPS Diluted (Quarterly) | -0.0006 |
| Gross Profit Margin (Quarterly) | 29.61% |
| Profit Margin (Quarterly) | -0.61% |
| Earnings Yield | 2.64% |
| Normalized Earnings Yield | 2.644 |